Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome

Yanping Gao,1,2,* Chen Chen,1,2,* Xijing Huang,2 Ya Liu,1 Zhou Zhou,1 Yan Pan1 1Department of Gastroenterology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China; 2Clinical Immunology Translational Medi...

Full description

Saved in:
Bibliographic Details
Main Authors: Gao Y, Chen C, Huang X, Liu Y, Zhou Z, Pan Y
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Journal of Inflammation Research
Subjects:
Online Access:https://www.dovepress.com/omentin-1-a-protective-adipokine-for-irritable-bowel-syndrome-peer-reviewed-fulltext-article-JIR
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832540605361684480
author Gao Y
Chen C
Huang X
Liu Y
Zhou Z
Pan Y
author_facet Gao Y
Chen C
Huang X
Liu Y
Zhou Z
Pan Y
author_sort Gao Y
collection DOAJ
description Yanping Gao,1,2,* Chen Chen,1,2,* Xijing Huang,2 Ya Liu,1 Zhou Zhou,1 Yan Pan1 1Department of Gastroenterology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China; 2Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yan Pan; Zhou Zhou, Sichuan Provincial People’s Hospital, 32 The First Ring Road West 2, Chengdu, Sichuan, 610072, People’s Republic of China, Email panyan2211@163.com; doublezhou2006@126.comIntroduction: Irritable bowel syndrome (IBS) is characterized by patients’ high level of suffering. There is increasing evidence for involvement of the immune system in this disease. Adipokines have been reported to be critical immunoregulators in many clinical conditions, including gastrointestinal (GI) inflammatory diseases. Our study aimed to investigate associations of omentin-1 (a newly discovered adipokine) with IBS.Methods: In the current study, serum levels of omentin-1 were measured in 209 patients with IBS (including three subtypes) and 188 healthy controls by enzyme-linked immunosorbent assay (ELISA). The somatic symptoms of IBS were determined by the 5-item IBS symptoms severity score (IBS-SSS), quality of life (QOL) by 34-item IBS-QOL questionnaire, and psychological disorders by Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Visceral Sensitivity Index (VSI). Therapeutic effect of omentin-1 for IBS was investigated in a 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced IBS mouse model.Results: We found that serum levels of omentin-1 were significantly decreased in patients with the diarrhea-predominant IBS (IBS-D) subtype (not the constipation or alternating subtype) compared to those in healthy subjects. Patients with lower serum omentin-1 levels suffered from higher severity of somatic symptoms (abdominal pain and distention, flatulence, rumbling), lower QOL, and worse psychological status. In a one-year follow-up, serum omentin-1 levels showed potential to reflect the disease progression. Additionally, lower omentin-1 levels were found to be accompanied with higher levels of serum pro-inflammatory cytokine concentrations in patients with IBS-D. Supplement of omentin-1 was protective against visceral hypersensitivity and mucosal inflammation in an IBS mouse model.Discussion: Our findings highlight the potential value of serum omentin-1 levels as an innovative biomarker in IBS, emphasizing its significance in improving clinical treatment and management of the disease.Keywords: irritable bowel syndrome, adipokine, omentin-1, clinical symptoms, quality of life, psychological symptoms
format Article
id doaj-art-726c3ed8ffce4d6f97ffd50f1a75af56
institution Kabale University
issn 1178-7031
language English
publishDate 2025-02-01
publisher Dove Medical Press
record_format Article
series Journal of Inflammation Research
spelling doaj-art-726c3ed8ffce4d6f97ffd50f1a75af562025-02-04T17:15:41ZengDove Medical PressJournal of Inflammation Research1178-70312025-02-01Volume 181689170199873Omentin-1, a Protective Adipokine for Irritable Bowel SyndromeGao YChen CHuang XLiu YZhou ZPan YYanping Gao,1,2,* Chen Chen,1,2,* Xijing Huang,2 Ya Liu,1 Zhou Zhou,1 Yan Pan1 1Department of Gastroenterology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China; 2Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China*These authors contributed equally to this workCorrespondence: Yan Pan; Zhou Zhou, Sichuan Provincial People’s Hospital, 32 The First Ring Road West 2, Chengdu, Sichuan, 610072, People’s Republic of China, Email panyan2211@163.com; doublezhou2006@126.comIntroduction: Irritable bowel syndrome (IBS) is characterized by patients’ high level of suffering. There is increasing evidence for involvement of the immune system in this disease. Adipokines have been reported to be critical immunoregulators in many clinical conditions, including gastrointestinal (GI) inflammatory diseases. Our study aimed to investigate associations of omentin-1 (a newly discovered adipokine) with IBS.Methods: In the current study, serum levels of omentin-1 were measured in 209 patients with IBS (including three subtypes) and 188 healthy controls by enzyme-linked immunosorbent assay (ELISA). The somatic symptoms of IBS were determined by the 5-item IBS symptoms severity score (IBS-SSS), quality of life (QOL) by 34-item IBS-QOL questionnaire, and psychological disorders by Patient Health Questionnaire (PHQ-9), Hospital Anxiety and Depression Scale (HADS), Visceral Sensitivity Index (VSI). Therapeutic effect of omentin-1 for IBS was investigated in a 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced IBS mouse model.Results: We found that serum levels of omentin-1 were significantly decreased in patients with the diarrhea-predominant IBS (IBS-D) subtype (not the constipation or alternating subtype) compared to those in healthy subjects. Patients with lower serum omentin-1 levels suffered from higher severity of somatic symptoms (abdominal pain and distention, flatulence, rumbling), lower QOL, and worse psychological status. In a one-year follow-up, serum omentin-1 levels showed potential to reflect the disease progression. Additionally, lower omentin-1 levels were found to be accompanied with higher levels of serum pro-inflammatory cytokine concentrations in patients with IBS-D. Supplement of omentin-1 was protective against visceral hypersensitivity and mucosal inflammation in an IBS mouse model.Discussion: Our findings highlight the potential value of serum omentin-1 levels as an innovative biomarker in IBS, emphasizing its significance in improving clinical treatment and management of the disease.Keywords: irritable bowel syndrome, adipokine, omentin-1, clinical symptoms, quality of life, psychological symptomshttps://www.dovepress.com/omentin-1-a-protective-adipokine-for-irritable-bowel-syndrome-peer-reviewed-fulltext-article-JIRirritable bowel syndromeadipokineomentin-1clinical symptomsquality of lifepsychological symptoms
spellingShingle Gao Y
Chen C
Huang X
Liu Y
Zhou Z
Pan Y
Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
Journal of Inflammation Research
irritable bowel syndrome
adipokine
omentin-1
clinical symptoms
quality of life
psychological symptoms
title Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
title_full Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
title_fullStr Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
title_full_unstemmed Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
title_short Omentin-1, a Protective Adipokine for Irritable Bowel Syndrome
title_sort omentin 1 a protective adipokine for irritable bowel syndrome
topic irritable bowel syndrome
adipokine
omentin-1
clinical symptoms
quality of life
psychological symptoms
url https://www.dovepress.com/omentin-1-a-protective-adipokine-for-irritable-bowel-syndrome-peer-reviewed-fulltext-article-JIR
work_keys_str_mv AT gaoy omentin1aprotectiveadipokineforirritablebowelsyndrome
AT chenc omentin1aprotectiveadipokineforirritablebowelsyndrome
AT huangx omentin1aprotectiveadipokineforirritablebowelsyndrome
AT liuy omentin1aprotectiveadipokineforirritablebowelsyndrome
AT zhouz omentin1aprotectiveadipokineforirritablebowelsyndrome
AT pany omentin1aprotectiveadipokineforirritablebowelsyndrome